Darexaban
Darexaban (YM150) is a direct inhibitor of factor Xa created by Astellas Pharma. It is an experimental drug that acts as an anticoagulant and antithrombotic to prevent venous thromboembolism after a major orthopaedic surgery, stroke in patients with atrial fibrillation and possibly ischemic events in acute coronary syndrome. It is used in form of the maleate. The development of darexaban was discontinued in September 2011.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Darexaban
Darexaban (YM150) is a direct inhibitor of factor Xa created by Astellas Pharma. It is an experimental drug that acts as an anticoagulant and antithrombotic to prevent venous thromboembolism after a major orthopaedic surgery, stroke in patients with atrial fibrillation and possibly ischemic events in acute coronary syndrome. It is used in form of the maleate. The development of darexaban was discontinued in September 2011.
has abstract
Darexaban (YM150) is a direct ...... iscontinued in September 2011.
@en
Darexaban, già noto con la sig ...... lla sindrome coronarica acuta.
@it
داركزبان (YM150) هو مانعٌ مباش ...... ّف تطويره في سبتمبر عام 2011م.
@ar
alternative name
YM150
@en
IUPAC name
N-[2-Hydroxy-6-(4-methoxybenzamido)phenyl]-4-(4-methyl-1,4-diazepan-1-yl)benzamide
@en
Wikipage page ID
35,019,978
page length (characters) of wiki page
Wikipage revision ID
1,023,482,814
Link from a Wikipage to another Wikipage
ImageFile
@en
imagesize
OtherNames
YM150
@en
PIN
N-[2-Hydroxy-6-phenyl]-4-benzamide
@en
wikiPageUsesTemplate
hypernym
comment
Darexaban (YM150) is a direct ...... iscontinued in September 2011.
@en
Darexaban, già noto con la sig ...... lla sindrome coronarica acuta.
@it
داركزبان (YM150) هو مانعٌ مباش ...... ّف تطويره في سبتمبر عام 2011م.
@ar
label
Darexaban
@en
Darexaban
@it
داركزبان
@ar